Tibor Mezei

This inventor holds 36 USPTO granted patents and 5 published patent applications and 7 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Egyt Gyogyszervegyeszeti Gyar, Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, Egis Gyogyszergyar. Active years: 1978-2015.

USPTO Granted Patents = 36 (Patent Applications = 5)

% Patents Active = 72.2

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 76(Granted Patents)

Company Filing History:

11 out of 62

Egyt Gyogyszervegyeszeti Gyar

patents

6 out of 16

Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag

Egis Gyogyszergyar Rt.

patents

5. 3 out of 296

Les Laboratoires Servier

patents

6. 2 out of 3

Egis Gyogyszergyar Nyrt

9. 1 out of 834,411

Other

patents

Years Active: 1978-2015

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

High-Purity Intermediates

Oxime Ethers

Piperazine Derivatives

ACE Inhibitors

Bicycloheptane

Plant Growth Regulators

Cyclododecanone

Antianginal Activity

Fodder Compositions

Trisubstituted Cycloalkanes

Substituted Styrene

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9169265 - Process for preparing pharmaceutical compounds and intermediate compounds (2015-10-27),

2. 8394993 - Process for the preparation of pharmaceutical intermediates (2013-03-12),

3. 8217200 - [object Object] (2012-07-10),

4. 8097616 - Process for preparation of high-purity meloxicam and meloxicam potassium salt (2012-01-17),

5. 7960558 - Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof (2011-06-14),

6. 7910591 - Piperazine derivatives of alkyl oxindoles (2011-03-22),

7. 7851627 - Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates (2010-12-14),

8. 7786129 - Piperazine derivatives of dialkyl oxindoles (2010-08-31),

9. 7326794 - Process for the preparation of high purity perindopril and intermediates useful in the synthesis (2008-02-05),

10. 7279595 - Process for the preparation of high purity perindopril (2007-10-09),

11. 7060842 - [object Object] (2006-06-13),

12. 6624201 - HIGH PURITY (1R,2S,4R)-(−)-2-[(2′-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-[PHENYL]-1,7,7 -TRI-[METHYL]-BICYCLO [2.2.1]HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF AND A PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AS WELL AS MEDICAMENTS CONTAINING 1 OR MORE OF THESE COMPOUNDS AND THEIR USE (2003-09-23),

13. 6335469 - High purity (1R,2S,4R)-(-)-2-[(2′-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof (2002-01-01),

14. 6242386 - Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof (2001-06-05),

15. 5652270 - Pharmaceutical compositions containing bicycloheptane ether amines and a (1997-07-29),

Title: The Innovative Journey of Tibor Mezei

Introduction:

Tibor Mezei, a prolific inventor hailing from Budapest, Hungary, has left a remarkable imprint in the field of pharmaceutical compounds. With an impressive portfolio of 36 patents to his name, Mezei's groundbreaking work has revolutionized the process of pharmaceutical compound preparation.

Latest Patents:

Mezei's latest patents showcase his expertise in the realm of pharmaceuticals. One notable invention is the process for preparing the 2-acetoxi-5-(2-fluor-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-thieno[3,2-c]pyridine (prasugrel), a critical compound in therapeutic interventions. Additionally, Mezei has introduced novel crystalline forms of 5-trityl-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine, enhancing the efficiency of pharmaceutical intermediate preparation.

Career Highlights:

Mezei has made significant contributions to renowned companies such as Egyt Gyogyszervegyeszeti Gyar and Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag. His ingenuity and dedication have propelled these organizations to the forefront of pharmaceutical innovation.

Collaborations:

Throughout his career, Mezei has collaborated with esteemed professionals in the field, including Zoltan Budai and Gyula Simig. Together, they have synergized their expertise to create groundbreaking solutions in pharmaceutical research and development.

Conclusion:

In conclusion, Tibor Mezei's inventive spirit and relentless pursuit of excellence have solidified his position as a trailblazer in the field of pharmaceutical compounds. His patents stand as a testament to his innovation and unwavering commitment to advancing scientific discovery.